Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine

K. Hradská, T. Popková, M. Skořupová, J. Mihályová, T. Jelínek, J. Lančová, N. Schellong, R. Hájek

. 2022 ; 14 (-) : 1655-1661. [pub] 20220504

Jazyk angličtina Země Nový Zéland

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017223

Background: Infectious complications, especially febrile neutropenia, in hemato-oncological patients are associated with considerable morbidity, mortality and expenses. Remote monitoring of physiological functions and thus early detection of adverse events via telemedicine could improve the safety of these high-risk patients and save financial resources by shortening the time-to-antibiotics. Methods: Patients undergoing active cancer treatment in high risk of acquiring severe infection are selected and enrolled in this project. Each patient receives a digital blood pressure monitor, an infrared thermometer and a mobile hub (cell phone). In the comfort of their homes, patients measure their blood pressure/pulse and body temperature regularly or whenever they feel unwell. The obtained data are encrypted and forwarded via the mobile hub to the password-protected portal. The values registered outside the set-up range trigger the alarms, which are immediately sent to the designated physician who can check the portal in real-time from any device with an Internet connection, contact the patient, if need be, and initiate the anti-infective therapy almost instantly after the first symptoms occur. Results: Fifty hemato-oncological patients were recruited between March 1, 2018 and August 1, 2020. Two hundred ninety-seven alarms of body temperature were registered and checked by the physician and patients were contacted in 18.5% of the cases (55/297). Among these 55 events, 13 required medical assistance, which makes it approximately one-quarter of all conducted telephone interventions (23.4%) and neither septic shock nor death due to treatment-related toxicity occurred. Conclusion: Telemedicine seems like a useful tool to improve the safety of high risk hemato-oncological patients when treatment-related infectious complications are concerned.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017223
003      
CZ-PrNML
005      
20220720100140.0
007      
ta
008      
220718s2022 nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/CMAR.S348923 $2 doi
035    __
$a (PubMed)35547597
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Hradská, Katarína $u Faculty of Science, University of Ostrava, Ostrava, Czech Republic $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000316602527
245    10
$a Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine / $c K. Hradská, T. Popková, M. Skořupová, J. Mihályová, T. Jelínek, J. Lančová, N. Schellong, R. Hájek
520    9_
$a Background: Infectious complications, especially febrile neutropenia, in hemato-oncological patients are associated with considerable morbidity, mortality and expenses. Remote monitoring of physiological functions and thus early detection of adverse events via telemedicine could improve the safety of these high-risk patients and save financial resources by shortening the time-to-antibiotics. Methods: Patients undergoing active cancer treatment in high risk of acquiring severe infection are selected and enrolled in this project. Each patient receives a digital blood pressure monitor, an infrared thermometer and a mobile hub (cell phone). In the comfort of their homes, patients measure their blood pressure/pulse and body temperature regularly or whenever they feel unwell. The obtained data are encrypted and forwarded via the mobile hub to the password-protected portal. The values registered outside the set-up range trigger the alarms, which are immediately sent to the designated physician who can check the portal in real-time from any device with an Internet connection, contact the patient, if need be, and initiate the anti-infective therapy almost instantly after the first symptoms occur. Results: Fifty hemato-oncological patients were recruited between March 1, 2018 and August 1, 2020. Two hundred ninety-seven alarms of body temperature were registered and checked by the physician and patients were contacted in 18.5% of the cases (55/297). Among these 55 events, 13 required medical assistance, which makes it approximately one-quarter of all conducted telephone interventions (23.4%) and neither septic shock nor death due to treatment-related toxicity occurred. Conclusion: Telemedicine seems like a useful tool to improve the safety of high risk hemato-oncological patients when treatment-related infectious complications are concerned.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Popková, Tereza $u Faculty of Science, University of Ostrava, Ostrava, Czech Republic $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000158854218
700    1_
$a Skořupová, Michaela $u Faculty of Science, University of Ostrava, Ostrava, Czech Republic $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Mihályová, Jana $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Jelínek, Tomáš $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Lančová, Jana $u National Monitoring Center, Ostrava, Czech Republic
700    1_
$a Schellong, Norbert $u National Monitoring Center, Ostrava, Czech Republic
700    1_
$a Hájek, Roman $u Faculty of Science, University of Ostrava, Ostrava, Czech Republic $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
773    0_
$w MED00165412 $t Cancer management and research $x 1179-1322 $g Roč. 14, č. - (2022), s. 1655-1661
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35547597 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100136 $b ABA008
999    __
$a ind $b bmc $g 1816494 $s 1168465
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 14 $c - $d 1655-1661 $e 20220504 $i 1179-1322 $m Cancer management and research $n Cancer manag. res. $x MED00165412
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...